Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 56

GBT reaches unicorn status with $150m series A

Fresh funding for the EV battery company comes as Chinese automotive players are ramping up mobility investment efforts.

May 6, 2022

Daily Deal Round Up: May 5, 2022

The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.

May 5, 2022

Corporates help AFH2 reach initial close

Asahi Intecc, Eisai and Ohara were among the LPs of Africa-minded AAIC Investment’s second vehicle, following in the footsteps of corporate-backed Samurai Africa Fund 2.

May 5, 2022

Suzuken to seek out corporate venturing deals

The drug wholesaler’s CVC fund will have up to $39.3m in capital, and will be led by Suzuken's head of corporate strategy, Yuichi Yamamoto.

May 4, 2022

Daily Deal Round Up: May 3, 2022

Web3 services provider Venly and genomic analysis technology provider Genome Insight each raised $23m while Rui Ye Lian helped Cedarlake Capital close a $189m fund.

May 3, 2022

VisionNav visualises $80m

Meituan co-led the unmanned forklift producer’s series C-plus round, which came seven months after a first close that featured ByteDance and Lenovo.

May 3, 2022

Zepto receives $200m series D delivery

Kaiser Permanente backed the India-based rapid delivery challenger as it squares up against bigger rivals.

May 3, 2022

Daily Deal Round Up: April 29, 2022

Content personalisation technology provider Movable Ink and carbon-negative concrete developer Brimstone each raised $55m, with Intel and Amazon respectively among the investors.

Apr 29, 2022

Temasek takes $162m to Info Edge funds

Info Edge's corporate venturing activities are being boosted by Singapore-owned Temasek, which is committing 50% of the capital for three of its funds.

Apr 29, 2022

Daily Deal Round Up: April 28, 2022

Call centre software producer Replicant closed a $78m series B round backed by Salesforce Ventures while Ashvattha Therapeutics raised $69m from investors including strategic partner Huadong Medicine.

Apr 28, 2022
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here